Will Novavax Stock Rise Further With E.U. Decision In The Offing?

Will Novavax Stock Rise Further With E.U. Decision In The Offing?

Novavax stock (NASDAQ: NVAX) rose by about 12% over the last week (five trading days), outperforming the S&P 500 which was up around 1% over the same period. The stock also remains down by about 15% over the last month (21 trading days). There are a couple of factors driving the gains in the stock..